4//SEC Filing
Chee Conley 4
Accession 0000950170-23-068288
CIK 0001556263other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:28 PM ET
Size
5.5 KB
Accession
0000950170-23-068288
Insider Transaction Report
Form 4
Chee Conley
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2023-12-02+86,000→ 86,000 total→ Common Stock (86,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs will vest as to one third (1/3rd) of the shares underlying the award on December 31, 2024 and as to an additional one third (1/3rd) of such shares at the end of each successive year thereafter.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001883804
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:28 PM ET
- Size
- 5.5 KB